Filing metadata

Accession number
0000899243-23-013994
Form type
Form 4
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
May 26, 2023
Reporting period
May 18, 2023
Description
Insider transaction

Explore SEC Filings Hub